Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer.

[1]  P. Scardino,et al.  Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[2]  D. Kuban,et al.  Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. , 2005, The Journal of urology.

[3]  P. Scardino,et al.  Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. , 2004, The Journal of urology.

[4]  P. Scardino,et al.  Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy , 2004, Current treatment options in oncology.

[5]  D. Kuban,et al.  Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. , 2004, International journal of radiation oncology, biology, physics.

[6]  M. Kattan,et al.  Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  M. Kattan,et al.  Is year of radical prostatectomy a predictor of outcome in prostate cancer? , 2004, The Journal of urology.

[8]  D. Kuban,et al.  Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? , 2003, International journal of radiation oncology, biology, physics.

[9]  A. Hanlon,et al.  Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. , 2003, The Journal of urology.

[10]  A. D'Amico.  How to compare results after surgery or radiation for localized prostate carcinoma , 2002, Cancer.

[11]  L. Potters,et al.  Clinical investigation: prostateRadical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer , 2004 .

[12]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Vicini,et al.  Practical application of biochemical failure definitions: what to do and when to do it. , 2001, International journal of radiation oncology, biology, physics.

[14]  C. Reddy,et al.  Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[15]  J. Manola,et al.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. , 1999, The New England journal of medicine.

[16]  H. Levin,et al.  Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of Clinical Oncology.

[17]  E. Klein.  Radiation therapy versus radical prostatectomy in the PSA era: a urologist's view. , 1998, Seminars in radiation oncology.

[18]  A. D'Amico,et al.  Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. , 1997, International journal of radiation oncology, biology, physics.

[19]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[20]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[21]  D. Paulson.  Radiotherapy versus surgery for localized prostatic cancer. , 1987, The Urologic clinics of North America.

[22]  C. Reddy,et al.  Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. , 2000, Urology.